Centro de Investigação Biomédica da Católica recebe classificação de “Excelente” pela Fundação para a Ciência e a Tecnologia

The Católica Biomedical Research Centre (CBR), a research unit of the Católica Medical School, has been classified as ‘Excellent’ in the most recent evaluation by the Foundation for Science and Technology (FCT).

This recognition highlights the scientific quality, impact, and innovative capacity of the CBR, which conducts interdisciplinary research in the fields of biomedicine, biology, and complex systems, with a focus on fundamental and translational research aimed at advancing human health.

Established in 2022, CBR is part of the Católica - Luz Clinical Academic Center — a CBR – Católica Medical School partnership with Hospital da Luz Lisboa and the Union of Portuguese Misericórdias — promoting integration between research, education, and clinical practice.

The excellent rating strengthens UCP’s role in the national scientific landscape and consolidates CBR as a leading institution in biomedical research in Portugal.

Investigação e Inovação
Pedro Marques receives Endocrine Society Early Investigator Award 2025 for groundbreaking research into pituitary tumours
This award recognises his outstanding contributions to research into pituitary tumours and neuroendocrinology. Learn more about the distinguished Católica professor.
SACRU Investigação e Inovação
Applications are now open for the Summer Visiting Doctoral Research Fellowship at Boston College
To participate in the research program, doctoral students at the Universidade Católica must apply by January 31, 2025.
Católica Biomedical Research Center
2.5 million to drive a new era in the treatment of data generated in health research era no tratamento dos dados gerados em investigação em saúde
Católica's Biomedical Research Centre has won 2.5 million euros from the European Commission to revolutionise the treatment of data generated in health research, with CBeRa: Strategic Integration of Complex Networks and Systems for Advancing Biomedical Research. Find out more.